Atea Pharmaceuticals (AVIR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov13

Atea Pharmaceuticals released FY2025 Q3 earnings on November 12 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5319 (forecast USD -0.44)

00:00

Atea Pharmaceuticals released FY2025 9 Months Earnings on November 12 After-Market EST with actual revenue of USD 0 and EPS of USD -1.378

00:00

Nov5

Atea Pharmaceuticals to Release FY2025 Q3 Earnings on November 12 After-Market EST, Forecast EPS USD -0.44

00:06

Aug7

Atea Pharmaceuticals released FY2025 Semi-Annual Earnings on August 7 During-Market EST, Actual Revenue USD 0, Actual EPS USD -0.8458

20:00

Atea Pharmaceuticals released FY2025 Q2 earnings on August 7 During-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4437 (forecast USD -0.45)

20:00

Jul31

Atea Pharmaceuticals to release FY2025 Q2 earnings on August 7, during market hours EST, with forecasted EPS of USD -0.45

00:07